Results 231 to 240 of about 97,265 (298)

6822 Proptosis Improvement with Teprotumumab is Independent of Race, Ethnicity, Gender and Age from Three Global Randomized, Double-Masked, Placebo-Controlled Trials of Patients with Acute Thyroid Eye Disease (TED) [PDF]

George J. Kahaly, Sara T. Wester, Catherine Y. Liu, H. ten Kate, Elizabeth Conrad, Robert J. Holt, Yuji Hiromatsu   +6 more
openalex   +1 more source

Teprotumumab for treating active thyroid eye disease: A meta-analysis. [PDF]

Medicine (Baltimore)
Cong X, Pei L, Hu H.
europepmc   +1 more source

Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series [PDF]

Fabliha A Mukit, A. Manley, Akash B Patel, Marium Hashemi, Jacquelyn Laplant, James C. Fleming, Brian Fowler   +6 more
openalex   +1 more source

The Management of Thyroid Eye Disease: From Current Practice to Future Perspectives. [PDF]

Cureus
Dhaliwal NK, Razzaq L.
europepmc   +1 more source

Integrative transcriptomic profiling and machine learning reveal hypoxia-associated molecular signatures for precision diagnosis in thyroid eye disease. [PDF]

Hum Genomics
Qian W, Zhu T, Liu J, Wei Y, Yang L, Fang L, Sun J, Li Y, Fang S, Zhou H.   +9 more
europepmc   +1 more source

Thyrotropin and IgG from patients with Graves' disease induce class-II antigen on human thyroid cells [PDF]

, 1986
Drexhage, H. A., Gutekunst, R., Mansky, T., Schultek, T., Scriba, Peter Christian, Wenzel, B. E.   +5 more
core  

Correction: The role of IL-6 in thyroid eye disease: an update on emerging treatments. [PDF]

Front Ophthalmol (Lausanne)
Murdock J, Nguyen J, Hurtgen BJ, Andorfer C, Walsh J, Lin A, Tubbs C, Erickson K, Cockerham K.   +8 more
europepmc   +1 more source

Teprotumumab for Thyroid Eye Disease: Mechanism, Clinical Efficacy, and Current Challenges. [PDF]

Antibodies (Basel)
Zong Y, Qiu S, Yang M, Zhang J, Zou Y, Jing Y, Ohno-Matsui K, Kamoi K.   +7 more
europepmc   +1 more source

Transcriptomic Profiling of Orbital Fat Tissue and Ocular Surface Wash in Active Thyroid Eye Disease Requiring Urgent Orbital Decompression. [PDF]

Invest Ophthalmol Vis Sci
Petrácková A, Schovánek J, Karhanová M, Savara J, Nesnadná R, Kriegová E.   +5 more
europepmc   +1 more source